Showing results (531-540 of 607) with videos related to

Sort By:
Pageof 61
Environment International|February 1, 2016
Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case studyNancy B Beck, Richard A Becker, Neeraja Erraguntla, et al.
Archives of Toxicology|May 15, 2017
A primer on systematic reviews in toxicologySebastian Hoffmann, Rob B M de Vries, Martin L Stephens, et al.
Scientific Reports|March 10, 2018
Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutationsAndrea Wenzel, Janine Altmueller, Arif B Ekici, et al.
Journal of the American Society of Nephrology : JASN|July 28, 2018
Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease RecognitionKarl X Knaup, Thomas Hackenbeck, Bernt Popp, et al.
Nature Communications|August 20, 2025
Non-linear bonding trends in maleonitrile-1,2-dithiolate complexes of the transuranium actinidesNicholas B Beck, Cristian Celis-Barros, Madeline C Martelles, et al.
Human Molecular Genetics|February 23, 2010
Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expressionFrank Zaucke, Joana M Boehnlein, Sarah Steffens, et al.
European Journal of Haematology|February 15, 2023
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolationHannah Cherniawsky, Jordan Friedmann, Hamish Nicolson, et al.
Kidney International Reports|July 11, 2022
Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope RegistryLisa J Deesker, Sander F Garrelfs, Giorgia Mandrile, et al.
American Journal of Human Genetics|January 5, 2019
Mutations of ADAMTS9 Cause Nephronophthisis-Related CiliopathyYo Jun Choi, Jan Halbritter, Daniela A Braun, et al.
Kidney International Reports|February 5, 2024
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1Cristina Martin-Higueras, Lodovica Borghese, Armando Torres, et al.
Pageof 61